Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement

18 Nov 2013 14:35

RNS Number : 3098T
Maven Income & Growth VCT 4 PLC
18 November 2013
 

Interim Management Statement

 

Maven Income and Growth VCT 4 PLC (the Company) - quarter ended 30 September 2013

 

This Interim Management Statement, for the quarter ended 30 September 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 October 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 96.00p per Ordinary Share and 101.01p per C Share at 30 September 2013, after payment of the interim dividend on the Ordinary Shares, compared to 97.60p and 98.40p per share respectively at 30 June 2013;

· NAV total return2 of 125.3p per Ordinary Share at 30 September 2013, compared to 124.9p at 30 June 2013; and

· Interim dividend of 2.00p per Ordinary Share in respect of the year ending 31 December 2013, paid on 27 September 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 30 September 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 June 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 30 September 2013, a net amount of £139,826 was invested from the Ordinary Share portfolio in two unlisted companies; net proceeds of £402,967 were realised from the sale of short-dated UK treasury bills; a total of £432,553 of capital was returned from three unlisted companies against a cost of £508,811 and the full or partial disposals of four AIM quoted investments generated aggregate proceeds of £115,584 against a total cost of £103,855.

 

During the same period, the full or partial disposals of three AIM quoted investments from the C Share portfolio, generated aggregate proceeds of £48,118 against a total cost of £29,277.

 

3.

Recent developments

 

Between 1 October 2013 and the date of this Statement, £132,769 was invested in two unlisted companies; a total of £295,254 of capital was returned by two unlisted companies; and the partial disposal of an AIM quoted investment generated proceeds of £35,438 against a cost of £32,284.

 

In the same period, an investment of £112,000 in an unlisted company was made on behalf of the C Share portfolio and the sale of the unlisted investment in Espresso Group generated proceeds of £1,246,191. While the reduction of £253,809 against the carrying value of Espresso Group represents 6.5% of the net assets attributable to the C shares as at 30 September 2013, the Manager has taken the view that this was the optimum opportunity to secure an exit from a legacy investment acquired from the merger of the Company with Ortus VCT PLC earlier in 2013.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 July 2013 to 30 September 2013, or in the period from 1 October 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

18 November 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUWOSROOAAAAA
Date   Source Headline
19th Nov 201811:40 amRNSDirector/PDMR Shareholding
15th Nov 20183:36 pmRNSDirectorate Change
15th Nov 20183:01 pmRNSMerger Update: Approval of Scheme
8th Nov 20184:27 pmRNSNet Asset Value(s)
1st Nov 201812:31 pmRNSResult of General Meeting
8th Oct 20187:00 amRNSStatement re Proposed Merger
14th Sep 20183:37 pmRNSHalf-year Report
13th Sep 20186:16 pmRNSPossible Merger
31st Aug 20184:04 pmRNSNet Asset Value(s)
22nd Jun 20184:30 pmRNSIssue of Equity
15th Jun 20184:47 pmRNSStatement re DIS
18th May 20184:47 pmRNSNet Asset Value(s)
17th May 20184:30 pmRNSDividend Declaration
15th May 20181:49 pmRNSResult of AGM
24th Apr 20184:52 pmRNSIssue of Equity
13th Apr 201812:48 pmRNSIssue of Equity
13th Apr 201811:59 amRNSPublication of Suppl.Prospcts
6th Apr 20184:41 pmRNSStatement re Dividend Investment Scheme
6th Apr 20184:34 pmRNSAnnual Financial Report
6th Apr 20189:23 amRNSDirector/PDMR Shareholding
6th Apr 20189:22 amRNSDirector/PDMR Shareholding
5th Apr 20186:23 pmRNSIssue of Equity
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
8th Mar 20183:30 pmRNSDividend Declaration
6th Mar 20185:24 pmRNSTransaction in Own Shares
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
26th Feb 20184:25 pmRNSNet Asset Value(s)
6th Feb 20185:19 pmRNSDirector/PDMR Shareholding
6th Feb 20185:18 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:46 pmRNSPublication of Suppl.Prospcts
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
30th Nov 20174:27 pmRNSIssue of Equity
22nd Nov 20173:01 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:09 pmRNSStatement re NAV and Dividend Investment Scheme
9th Nov 20173:58 pmRNSNet Asset Value(s)
8th Nov 201710:10 amRNSResult of General Meeting
25th Oct 20173:00 pmRNSDividend Declaration
18th Oct 201710:43 amRNSReplacement Statement re Listing Application
17th Oct 20172:49 pmRNSStatement re Listing Application
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:48 pmRNSIssue of Equity
15th Sep 201710:08 amRNSStatement re NAV and Dividend Investment Scheme
8th Sep 20177:00 amRNSHalf-year Report
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
29th Aug 20174:11 pmRNSNet Asset Value(s)
10th Aug 20174:38 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.